Cognex (NASDAQ:CGNX) Shares Cross Below Two Hundred Day Moving Average – What’s Next?

Shares of Cognex Corporation (NASDAQ:CGNX – Get Free Report) passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $57.96 and traded as low as $51.80. Cognex shares last traded at $53.06, with a volume of 4,106,817 shares trading hands.

Key Stories Impacting Cognex

Here are the key news stories impacting Cognex this week:

  • Positive Sentiment: Third-quarter adjusted earnings were $0.53 per share, above estimates of $0.51–$0.52 and up from $0.33 a year earlier. Revenue rose 13% to $313.4 million, and reports highlighted a record quarter and increased 2026 guidance. Cognex Fiscal Q3 Adjusted Earnings, Revenue Increase; 2026 Guidance Raised
  • Positive Sentiment: Cognex raised its quarterly dividend 5.9%, from $0.085 to $0.09 per share. The annualized payout is $0.36, a 0.7% yield.
  • Neutral Sentiment: A valuation analysis suggested CGNX could be 33% undervalued after the results. This is an estimate rather than a company announcement, so its impact depends on investor confidence in the assumptions. Cognex Could Be 33% Undervalued Following Record Q3 And Raised Outlook
  • Negative Sentiment: Revenue came in just below analysts’ $313.62 million estimate, while the earnings beat was small. That gap may temper enthusiasm despite the year-over-year growth and improved outlook.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CGNX. Weiss Ratings upgraded shares of Cognex from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. The Goldman Sachs Group reissued a “buy” rating and issued a $91.00 price objective on shares of Cognex in a research note on Friday, August 7th. HSBC lowered shares of Cognex from a “buy” rating to a “hold” rating and set a $65.00 target price on the stock. in a research note on Monday, August 10th. Zacks Research cut shares of Cognex from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Finally, Truist Financial set a $74.00 price target on shares of Cognex and gave the company a “hold” rating in a research report on Monday, October 5th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $75.57.

Get Our Latest Stock Analysis on CGNX

Cognex Stock Performance

The stock’s 50-day moving average is $59.65 and its 200 day moving average is $57.96. The stock has a market capitalization of $8.93 billion, a PE ratio of 51.52 and a beta of 1.49.

Cognex (NASDAQ:CGNX – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The scientific and technical instruments company reported $0.53 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.01. The firm had revenue of $313.39 million during the quarter, compared to analysts’ expectations of $313.62 million. Cognex had a net margin of 16.05% and a return on equity of 13.50%. Cognex’s quarterly revenue was up 13.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.33 earnings per share. Analysts expect that Cognex Corporation will post 1.68 earnings per share for the current year.

Cognex Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 3rd. Stockholders of record on Thursday, November 19th will be issued a $0.09 dividend. This represents a $0.36 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, November 19th. This is an increase from Cognex’s previous quarterly dividend of $0.0850. Cognex’s dividend payout ratio (DPR) is presently 33.01%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in Cognex during the 2nd quarter worth approximately $1,158,123,000. Pictet Asset Management Holding SA increased its holdings in shares of Cognex by 2.7% in the third quarter. Pictet Asset Management Holding SA now owns 5,985,986 shares of the scientific and technical instruments company’s stock valued at $363,002,000 after purchasing an additional 156,108 shares during the period. Jupiter Topco LLC acquired a new position in shares of Cognex in the second quarter valued at approximately $161,425,000. Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Cognex by 0.5% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,227,288 shares of the scientific and technical instruments company’s stock worth $135,085,000 after purchasing an additional 11,927 shares during the last quarter. Finally, Janus Henderson Group PLC raised its stake in shares of Cognex by 81.0% during the first quarter. Janus Henderson Group PLC now owns 2,660,411 shares of the scientific and technical instruments company’s stock worth $130,320,000 after purchasing an additional 1,190,434 shares during the last quarter. Hedge funds and other institutional investors own 88.12% of the company’s stock.

About Cognex

(Get Free Report)

Cognex Corporation develops machine vision and industrial identification technologies that help manufacturers and businesses automate inspection, measurement, guidance, and tracking processes. Its systems use cameras, sensors, software, and artificial intelligence to analyze images and identify products, defects, components, and other objects.

The company’s product portfolio includes vision systems, industrial cameras, vision sensors, barcode readers, optical character recognition tools, three-dimensional vision systems, and machine vision software.

Read More

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.